Evidence map›Paper›PMID 38621478›Full record

ArticleBiological psychiatry. Cognitive neuroscience and neuroimaging2024

Influences of RASopathies on Neuroanatomical Variation in Children.

Chloe Alexa McGhee, Hamed Honari, Monica Siqueiros-Sanchez, Yaffa Serur, Eric K van Staalduinen, David Stevenson, Jennifer L Bruno, Mira Michelle Raman, Tamar Green

Open access · greenAbstract read
In one paragraph

Article in Biological psychiatry. Cognitive neuroscience and neuroimaging, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it, 9 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Biomarker Landscape in RASopathies.International journal of molecular sciences · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Chloe Alexa McGheeDepartment of Psychiatry & Behavioral Sciences, Stanford University, Stanford, California. Electronic address: camcghee@stanford.edu.
Hamed HonariDepartment of Psychiatry & Behavioral Sciences, Stanford University, Stanford, California.
Monica Siqueiros-SanchezDepartment of Psychiatry & Behavioral Sciences, Stanford University, Stanford, California.
Yaffa SerurDepartment of Psychiatry & Behavioral Sciences, Stanford University, Stanford, California.
Eric K van StaalduinenDepartment of Psychiatry & Behavioral Sciences, Stanford University, Stanford, California.
David StevensonDivision of Medical Genetics, Stanford University, Stanford, California.
Jennifer L BrunoDepartment of Psychiatry & Behavioral Sciences, Stanford University, Stanford, California.
Mira Michelle RamanDepartment of Psychiatry & Behavioral Sciences, Stanford University, Stanford, California.
Tamar GreenDepartment of Psychiatry & Behavioral Sciences, Stanford University, Stanford, California.
Stanford University · USStanford Medicine · US

Funding

NEUROPSYCHIATRIC-MOLECULAR ASSOCIATIONS IN FRAGILE X SYNR01MH050047 · NIMH · STANFORD UNIVERSITY · PI REISS, ALLAN L · 1993 to 2022
$12.5M
TRAINING FOR CHILD PSYCHIATRY AND CHILD DEVELOPMENTT32MH019908 · NIMH · STANFORD UNIVERSITY · PI IAN H GOTLIB, DAVID S HONG · 1993 to 2026
$6.3M
Gaining insights: the effects of the RMK gain-of-function mutations on brain development and neurodevelopmental disordersR01HD108684 · NICHD · STANFORD UNIVERSITY · PI Tamar Green · 2022 to 2026
$3.0M
Ras/MAPK Mutations Effects on the Developing BrainK23HD090209 · NICHD · STANFORD UNIVERSITY · PI GREEN, TAMAR · 2018 to 2022
$837k
Toward a neuroscientific understanding of the interaction between Down syndrome and Alzheimer's disease pathologyK01AG083224 · NIA · STANFORD UNIVERSITY · PI JENNIFER L BRUNO · 2023 to 2026
$503k
NIA NIH HHS K01 AG083224NICHD NIH HHS K23 HD090209NICHD NIH HHS R01 HD108684NIMH NIH HHS R01 MH050047NIMH NIH HHS T32 MH019908
6 · The paper itself

Abstract

backgroundRASopathies are a group of disorders characterized by pathogenic mutations in the Ras/mitogen-activated protein kinase (Ras/MAPK) signaling pathway. Distinct pathogenic variants in genes encoding proteins in the Ras/MAPK pathway cause Noonan syndrome (NS) and neurofibromatosis type 1 (NF1), which are associated with increased risk for autism spectrum disorder and attention-deficit/hyperactivity disorder.

methodsThis study examined the effect of RASopathies (NS and NF1) on human neuroanatomy, specifically on surface area (SA), cortical thickness (CT), and subcortical volumes. Using vertex-based analysis for cortical measures and Desikan region of interest parcellation for subcortical volumes, we compared structural T1-weighted images of children with RASopathies (n = 91, mean age = 8.81 years, SD = 2.12) to those of sex- and age-matched typically developing children (n = 74, mean age = 9.07 years, SD = 1.77).

resultsCompared with typically developing children, RASopathies had convergent effects on SA and CT, exhibiting increased SA in the precentral gyrus, decreased SA in occipital regions, and thinner CT in the precentral gyrus. RASopathies exhibited divergent effects on subcortical volumes, with syndrome-specific influences from NS and NF1. Overall, children with NS showed decreased volumes in striatal and thalamic structures, and children with NF1 displayed increased volumes in the hippocampus, amygdala, and thalamus.

conclusionsOur study reveals the converging and diverging neuroanatomical effects of RASopathies on human neurodevelopment. The convergence of cortical effects on SA and CT indicates a shared influence of Ras/MAPK hyperactivation on the human brain. Therefore, considering these measures as objective outcome indicators for targeted treatments is imperative.

Indexed as

Magnetic Resonance ImagingNeurofibromatosis 1Noonan SyndromeBrainCerebral CortexChildFemaleHumansMaleras Proteinsras ProteinsNeuroanatomicalNeurofibromatosis type 1NeuroimagingNoonan syndromeRASopathies

Identifiers

PMID38621478
PMCPMC11381177
OpenAlexW4394823954

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.